Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer: real-world outcomes versus clinical trial results
Verschueren, Marjon V, Dijs, Talitha, Gulikers, Judith L, Veelen, Ard van, Croes, Sander, Hendriks, Lizza El, Smit, Adrianus Aj, Bloem, Lourens T, Egberts, Antoine Cg, van de Garde, Ewoudt Mw, Peters, Bas Jm
Published in Immunotherapy (01.08.2023)
Published in Immunotherapy (01.08.2023)
Get full text
Journal Article